A new and efficient enrichment method for metagenomic sequencing of Monkeypox virus.

Genome sequencing Host DNA depletion Human monkeypox (hMPX) Metagenomics Monkeypox virus (MPXV) Viral surveillance

Journal

BMC genomics
ISSN: 1471-2164
Titre abrégé: BMC Genomics
Pays: England
ID NLM: 100965258

Informations de publication

Date de publication:
17 Jan 2023
Historique:
received: 28 07 2022
accepted: 04 01 2023
entrez: 17 1 2023
pubmed: 18 1 2023
medline: 20 1 2023
Statut: epublish

Résumé

The methodology described in previous literature for Monkeypox virus (MPXV) sequencing shows low efficiency when using metagenomic approaches. The aim of the present study was to evaluate a new fine-tuned method for extraction and enrichment of genomic MPXV DNA using clinical samples and to compare it to a non-enrichment metagenomic approach. A new procedure that allows sample enrichment in MPXV DNA, avoiding wasting the sequencing capacity in human DNA, was designed. This procedure consisted of host DNA depletion using a saponin/NaCl combination treatment and DNase, together with high g-force centrifugations. After typical quality control, samples using the enrichment method contained around 96% of reads not classified as human DNA, while the non-enrichment protocol showed around 5-10%. When reads not belonging to Orthopoxvirus were removed, enriched samples kept about 50% of the original read counts, while non-enriched ones kept only 2-7%. Results showed a very significant improvement in sequencing efficiency, increasing the number of reads belonging to MPXV, the depth of coverage and the trustworthiness of the consensus sequences. This, in turn, allows for more samples to be included in a single cartridge, reducing costs and time to diagnosis, which can be very important factors when dealing with a contagious disease.

Sections du résumé

BACKGROUND BACKGROUND
The methodology described in previous literature for Monkeypox virus (MPXV) sequencing shows low efficiency when using metagenomic approaches. The aim of the present study was to evaluate a new fine-tuned method for extraction and enrichment of genomic MPXV DNA using clinical samples and to compare it to a non-enrichment metagenomic approach.
RESULTS RESULTS
A new procedure that allows sample enrichment in MPXV DNA, avoiding wasting the sequencing capacity in human DNA, was designed. This procedure consisted of host DNA depletion using a saponin/NaCl combination treatment and DNase, together with high g-force centrifugations. After typical quality control, samples using the enrichment method contained around 96% of reads not classified as human DNA, while the non-enrichment protocol showed around 5-10%. When reads not belonging to Orthopoxvirus were removed, enriched samples kept about 50% of the original read counts, while non-enriched ones kept only 2-7%.
CONCLUSIONS CONCLUSIONS
Results showed a very significant improvement in sequencing efficiency, increasing the number of reads belonging to MPXV, the depth of coverage and the trustworthiness of the consensus sequences. This, in turn, allows for more samples to be included in a single cartridge, reducing costs and time to diagnosis, which can be very important factors when dealing with a contagious disease.

Identifiants

pubmed: 36650445
doi: 10.1186/s12864-023-09114-w
pii: 10.1186/s12864-023-09114-w
pmc: PMC9847149
doi:

Substances chimiques

DNA, Viral 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

29

Subventions

Organisme : SERGAS-Galician Healthcare Service
ID : Innova Saúde
Organisme : SERGAS-Galician Healthcare Service
ID : Innova Saúde
Organisme : SERGAS-Galician Healthcare Service
ID : Innova Saúde
Organisme : SERGAS-Galician Healthcare Service
ID : Innova Saúde
Organisme : Instituto de Salud Carlos III
ID : CIBERINFEC
Organisme : Instituto de Salud Carlos III
ID : PI20/00413
Organisme : Instituto de Salud Carlos III
ID : CIBERINFEC

Informations de copyright

© 2023. The Author(s).

Références

Genome Biol. 2021 Sep 14;22(1):266
pubmed: 34521459
Sci Rep. 2022 Jun 24;12(1):10768
pubmed: 35750759
Infect Dis Clin North Am. 2019 Dec;33(4):1027-1043
pubmed: 30981594
J Clin Microbiol. 2016 Apr;54(4):919-27
pubmed: 26763966
Nucleic Acids Res. 2021 Jul 2;49(W1):W293-W296
pubmed: 33885785
Bioinformatics. 2016 Oct 1;32(19):3047-8
pubmed: 27312411
Nat Biotechnol. 2019 Jul;37(7):783-792
pubmed: 31235920
Nat Med. 2022 Aug;28(8):1569-1572
pubmed: 35750157
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242
Microbiol Resour Announc. 2020 Mar 5;9(10):
pubmed: 32139560
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Bioinformatics. 2014 May 1;30(9):1312-3
pubmed: 24451623
Bioinformatics. 2020 Feb 15;36(4):1303-1304
pubmed: 31553437
PLoS Comput Biol. 2017 Jun 8;13(6):e1005595
pubmed: 28594827
J Gen Microbiol. 1962 Nov;29:523-9
pubmed: 14004140
PLoS One. 2016 Oct 5;11(10):e0163962
pubmed: 27706213
Euro Surveill. 2022 Jul;27(29):
pubmed: 35866435
J Comput Biol. 2012 May;19(5):455-77
pubmed: 22506599
PLoS Comput Biol. 2022 Jan 24;18(1):e1009802
pubmed: 35073327
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Respir Res. 2019 Nov 27;20(1):265
pubmed: 31775777
Bull World Health Organ. 1980;58(2):165-82
pubmed: 6249508
Genome Biol. 2019 Jan 8;20(1):8
pubmed: 30621750
Genome Biol. 2019 Nov 28;20(1):257
pubmed: 31779668
Brief Bioinform. 2008 Jul;9(4):286-98
pubmed: 18372315
Lancet Infect Dis. 2018 Mar;18(3):246
pubmed: 29361427

Auteurs

Pablo Aja-Macaya (P)

Microbiology Research Group, Biomedical Research Institute of A Coruña (INIBIC) - University Hospital of A Coruña (CHUAC) - CIBER of Infectious Diseases (CIBERINFEC), Servicio de Microbiología, 3ª planta, Edificio Sur, Hospital Universitario, As Xubias, 15006, A Coruña, Spain.

Soraya Rumbo-Feal (S)

Microbiology Research Group, Biomedical Research Institute of A Coruña (INIBIC) - University Hospital of A Coruña (CHUAC) - CIBER of Infectious Diseases (CIBERINFEC), Servicio de Microbiología, 3ª planta, Edificio Sur, Hospital Universitario, As Xubias, 15006, A Coruña, Spain.

Margarita Poza (M)

Microbiology Research Group, Biomedical Research Institute of A Coruña (INIBIC) - University Hospital of A Coruña (CHUAC) - CIBER of Infectious Diseases (CIBERINFEC), Servicio de Microbiología, 3ª planta, Edificio Sur, Hospital Universitario, As Xubias, 15006, A Coruña, Spain.
University of A Coruña (UDC) - Center for Advanced Research (CICA), Facultad de Ciencias, Campus Zapateira, 15008, A Coruña, Spain.

Angelina Cañizares (A)

Microbiology Research Group, Biomedical Research Institute of A Coruña (INIBIC) - University Hospital of A Coruña (CHUAC) - CIBER of Infectious Diseases (CIBERINFEC), Servicio de Microbiología, 3ª planta, Edificio Sur, Hospital Universitario, As Xubias, 15006, A Coruña, Spain.

Juan A Vallejo (JA)

Microbiology Research Group, Biomedical Research Institute of A Coruña (INIBIC) - University Hospital of A Coruña (CHUAC) - CIBER of Infectious Diseases (CIBERINFEC), Servicio de Microbiología, 3ª planta, Edificio Sur, Hospital Universitario, As Xubias, 15006, A Coruña, Spain. juan.andres.vallejo.vidal@sergas.es.

Germán Bou (G)

Microbiology Research Group, Biomedical Research Institute of A Coruña (INIBIC) - University Hospital of A Coruña (CHUAC) - CIBER of Infectious Diseases (CIBERINFEC), Servicio de Microbiología, 3ª planta, Edificio Sur, Hospital Universitario, As Xubias, 15006, A Coruña, Spain. german.bou.arevalo@sergas.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH